Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 76,320 | 22,263 | 27,771 | 43,113 | 30,017 |
| Gross Profit | 76,320 | 22,263 | 27,771 | 43,113 | 30,017 |
| Operating Expenses | 41,616 | 48,433 | 55,310 | 52,783 | 52,774 |
| Operating Income | 34,704 | -26,170 | -27,539 | -9,670 | -22,757 |
| Other Income | -19,591 | -12,421 | -11,746 | -12,120 | -10,094 |
| Pre-tax Income | 15,113 | -38,591 | -39,285 | -21,790 | -32,851 |
| Income Tax | N/A | 39 | 44 | -12 | N/A |
| Net Income Continuous | 15,113 | -38,630 | -39,329 | -21,778 | -32,851 |
| Net Income | $15,113 | $-38,630 | $-39,329 | $-21,784 | $-32,851 |
| EPS Basic Total Ops | 0.54 | -1.34 | -1.28 | -0.63 | -1.14 |
| EPS Basic Continuous Ops | 0.54 | -1.34 | -1.28 | -0.63 | -1.14 |
| EPS Diluted Total Ops | 0.52 | -1.34 | -1.28 | -0.63 | -1.14 |
| EPS Diluted Continuous Ops | 0.52 | -1.34 | -1.28 | -0.63 | -1.14 |
| EPS Diluted Before Non-Recurring Items | 0.52 | -1.34 | -1.28 | -0.72 | -1.14 |
| EBITDA(a) | $34,184 | $-27,166 | $-28,600 | $-11,371 | $-24,727 |